Figure 9From: Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression LCL85 treatment decreases Bcl-xL protein levels in metastatic human colon and mammary carcinoma cells. A & B. Metastatic human colon (A) and mammary (B) carcinoma cells were treated with LCL85 at the indicated doses for approximately 24Â h and analyzed for the indicated proteins by Western blotting analysis.Back to article page